AC Immune SA (ACIU)
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Address
EPFL INNOVATION PARK, BUILDING B
1015 LAUSANNE, V8 00000
Founded
2003
Number of Employees
161
Website
http://www.acimmune.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)